# A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

> **NCT01781442** · — · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **DRUG:** Temsirolimus

## Key facts

- **NCT ID:** NCT01781442
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781442, "A Post Marketing Surveillance As Required By Philippine Food And Drug Administration". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01781442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*